Bionova Capital is a healthcare-focused venture capital firm, investing in early-stage startups across Europe.
Bionova Capital, previously known as Hovione Capital, is a healthcare-focused venture capital firm, investing in early-stage life science companies. It was founded in 2015 by the shareholders of Hovione, one of the largest pharmaceutical companies in Portugal, with manufacturing and research operations in USA, Ireland, China and Portugal. Bionova Capital invests in groundbreaking therapeutics, medtech and digital health startups across Europe.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 18, 2022
Delox
|
Seed | €750K | Biotechnology | — |
Aug 9, 2021
SolasCure
|
Series A | £15M | Biopharma | — |
Mar 23, 2021
Adapttech
|
Series Unknown | £2M | Biotechnology | Yes |
Nov 13, 2019
CellmAbs
|
Seed | $1.60M | Biotechnology | — |
Jul 1, 2018
Delox
|
Seed | €300K | Biotechnology | — |